Horrell Capital Management’s Tvardi Therapeutics TVRD Stock Holding History

Horrell Capital Management’s Portfolio TVRD Stock Details TVRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-6	Closed	-$1K	–	217
2023 Q2	$1K	Hold	6	–	–	﹤0.01%	210
2023 Q1	$1K	Hold	6	–	–	﹤0.01%	207
2022 Q4	$2K	Hold	6	–	–	﹤0.01%	201
2022 Q3	$2K	Hold	6	–	–	﹤0.01%	196
2022 Q2	$2K	Hold	6	–	–	﹤0.01%	193
2022 Q1	$2K	Hold	6	–	–	﹤0.01%	191
2021 Q4	$2K	Hold	6	–	–	﹤0.01%	187
2021 Q3	$3K	Hold	6	–	–	﹤0.01%	187
2021 Q2	$3K	Hold	6	–	–	﹤0.01%	190
2021 Q1	$4K	Hold	6	–	–	﹤0.01%	184
2020 Q4	$3K	Hold	6	–	–	﹤0.01%	175
2020 Q3	$3K	Hold	6	–	–	﹤0.01%	168
2020 Q2	$3K	Hold	6	–	–	﹤0.01%	167
2020 Q1	$3K	Hold	6	–	–	﹤0.01%	163
2019 Q4	$3K	Hold	6	–	–	﹤0.01%	171
2019 Q3	$4K	Hold	6	–	–	﹤0.01%	173
2019 Q2	$4K	Hold	6	–	–	﹤0.01%	172
2019 Q1	$4K	Sell	6 -5	-45%	-$2.99K	﹤0.01%	174
2018 Q4	$5K	Hold	11	–	–	﹤0.01%	170
2018 Q3	$10K	Hold	11	–	–	0.01%	142
2018 Q2	$8K	Hold	11	–	–	﹤0.01%	151
2018 Q1	$5K	Buy	11 +5	+83%	+$2.42K	﹤0.01%	159
2017 Q4	$2K	Hold	6	–	–	﹤0.01%	169
2017 Q3	$3K	Hold	6	–	–	﹤0.01%	167
2017 Q2	$3K	Sell	6 -8	-57%	-$5.08K	﹤0.01%	163
2017 Q1	$9K	Hold	14	–	–	0.01%	138
2016 Q4	$5K	Hold	14	–	–	﹤0.01%	153
2016 Q3	$4K	Hold	14	–	–	﹤0.01%	151
2016 Q2	$2K	Buy	+14	New	+$3.05K	﹤0.01%	176

Other funds holding TVRD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IEFM

IQ EQ Fund Management Dublin 2, Ireland $1.32B AUM 31.52% 1-Year Est. Return

Horrell Capital Management's TVRD Position: Q3 2023 in Review

Horrell Capital Management sold out of Tvardi Therapeutics (TVRD) in Q3 2023, closing a stake of 6 shares — an estimated $1K sold.

Horrell Capital Management first reported a position in TVRD in Q2 2016 and held it in 29 quarters. The position peaked at $10K in Q3 2018. 121 funds tracked by Wall St. Rank hold TVRD as of Q3 2023.

Horrell Capital Management reported no remaining Tvardi Therapeutics position as of Q3 2023 after selling out during the quarter.
Horrell Capital Management sold 6 Tvardi Therapeutics shares in Q3 2023, an estimated $1K.
Horrell Capital Management first reported a position in Tvardi Therapeutics in Q2 2016 and held it in 29 quarters.
Horrell Capital Management's Tvardi Therapeutics position peaked at $10K in Q3 2018.
121 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q3 2023.

Based on Horrell Capital Management's 13F filing for Q3 2023, filed 1 Nov 2023.